Vertex Pharmaceuticals Incorporated (LON:0QZU)

Vertex Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 15, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	89,003	82,838	82,315	61,522	41,234	45,014
Market Cap Growth	12.71%	0.64%	33.80%	49.20%	-8.40%	5.89%
Enterprise Value	81,755	75,287	72,200	54,097	36,741	40,909
Last Close Price	346.38	320.91	319.55	236.58	163.63	171.91
PE Ratio	-	-	28.97	22.31	23.84	22.66
PS Ratio	10.36	9.41	10.62	8.30	7.37	9.90
PB Ratio	6.97	6.32	5.96	5.33	5.53	7.08
P/TBV Ratio	7.68	7.15	6.70	6.07	6.42	8.44
P/FCF Ratio	-	-	31.42	18.89	23.18	20.53
P/OCF Ratio	-	-	29.64	17.95	21.12	18.89
EV/Sales Ratio	9.86	8.55	9.32	7.30	6.57	9.00
EV/EBITDA Ratio	23.08	19.74	20.54	14.40	12.38	17.66
EV/EBIT Ratio	24.84	20.52	21.35	14.89	12.78	18.29
EV/FCF Ratio	-84.48	-	27.56	16.61	20.66	18.66
Debt / Equity Ratio	0.10	0.11	0.05	0.07	0.10	0.11
Debt / EBITDA Ratio	0.35	0.36	0.18	0.20	0.24	0.30
Debt / FCF Ratio	-	-	0.24	0.23	0.40	0.32
Asset Turnover	0.47	0.49	0.48	0.57	0.60	0.62
Inventory Turnover	4.79	5.14	7.38	8.87	8.97	10.62
Quick Ratio	2.12	2.17	3.60	4.46	4.04	4.02
Current Ratio	2.65	2.69	3.99	4.83	4.46	4.33
Return on Equity (ROE)	-5.64%	-3.15%	22.99%	27.67%	24.93%	36.71%
Return on Assets (ROA)	11.77%	12.68%	13.17%	17.33%	19.32%	19.02%
Return on Capital (ROIC)	14.73%	15.71%	16.22%	21.15%	23.51%	23.29%
Return on Capital Employed (ROCE)	23.10%	24.20%	22.50%	28.40%	34.50%	30.90%
Earnings Yield	-0.86%	-0.52%	3.45%	4.48%	4.20%	4.41%
FCF Yield	-1.09%	-0.76%	3.18%	5.29%	4.31%	4.87%
Buyback Yield / Dilution	1.20%	1.00%	-0.54%	0.31%	1.33%	-1.04%

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.